Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: North America Diverticular Treatment Market

4. Market Overview
    4.1. Overview
    4.2. Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Opportunities
    4.3. North America Diverticular Treatment Market Value Analysis and Forecast, 2017-2031

5. Key Insights
    5.1. Disease Prevalence & Incidence Rate
    5.2. Pipeline Analysis
    5.3. COVID-19 Impact Analysis

6. North America Diverticular Treatment Market Analysis and Forecast, by Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Type, 2017-2031
        6.3.1. Diverticulosis
        6.3.2. Diverticulitis
        6.3.3. Diverticular Hemorrhage
    6.4. Market Attractiveness Analysis, by Type

7. North America Diverticular Treatment Market Analysis and Forecast, by Treatment
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Treatment, 2017-2031
        7.3.1. Medication
            7.3.1.1. Pain Reliever
            7.3.1.2. Antibiotics
                7.3.1.2.1. Amebicides
                7.3.1.2.2. Sulfonamides
                7.3.1.2.3. Quinolones and Fluoroquinolones
                7.3.1.2.4. Lincomycin Derivatives
                7.3.1.2.5. Miscellaneous Antibiotics
            7.3.1.3. Anticholinergics/Antispasmodics
        7.3.2. Nutritional Supplements
        7.3.3. Probiotics
    7.4. Market Attractiveness Analysis, by Treatment

8. North America Diverticular Treatment Market Analysis and Forecast, by Route of Administration
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Route of Administration, 2017-2031
        8.3.1. Oral
        8.3.2. Parenteral
    8.4. Market Attractiveness Analysis, by Route of Administration

9. North America Diverticular Treatment Market Analysis and Forecast, by Distribution Channel
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by Distribution Channel, 2017-2031
        9.3.1. Hospital Pharmacies
        9.3.2. Retail Pharmacies
        9.3.3. Online Pharmacies
    9.4. Market Attractiveness Analysis, by Distribution Channel

10. North America Diverticular Treatment Market Analysis and Forecast, by Country
    10.1. Key Findings
    10.2. Market Value Forecast, by Country
        10.2.1. U.S.
        10.2.2. Canada
    10.3. Market Attractiveness Analysis, by Country

11. U.S. Diverticular Treatment Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Type, 2017-2031
        11.2.1. Diverticulosis
        11.2.2. Diverticulitis
        11.2.3. Diverticular Hemorrhage
    11.3. Market Value Forecast, by Treatment, 2017-2031
        11.3.1. Medication
            11.3.1.1. Pain Reliever
            11.3.1.2. Antibiotics
                11.3.1.2.1. Amebicides
                11.3.1.2.2. Sulfonamides
                11.3.1.2.3. Quinolones and Fluoroquinolones
                11.3.1.2.4. Lincomycin Derivatives
                11.3.1.2.5. Miscellaneous Antibiotics
            11.3.1.3. Anticholinergics/Antispasmodics
        11.3.2. Nutritional Supplements
        11.3.3. Probiotics
    11.4. Market Value Forecast, by Route of Administration, 2017-2031
        11.4.1. Oral
        11.4.2. Parenteral
    11.5. Market Value Forecast, by Distribution Channel, 2017-2031
        11.5.1. Hospital Pharmacies
        11.5.2. Retail Pharmacies
        11.5.3. Online Pharmacies
    11.6. Market Attractiveness Analysis
        11.6.1. By Type
        11.6.2. By Treatment
        11.6.3. By Route of Administration
        11.6.4. By Distribution Channel

12. Canada Diverticular Treatment Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Type, 2017-2031
        12.2.1. Diverticulosis
        12.2.2. Diverticulitis
        12.2.3. Diverticular Hemorrhage
    12.3. Market Value Forecast, by Treatment, 2017-2031
        12.3.1. Medication
            12.3.1.1. Pain Reliever
            12.3.1.2. Antibiotics
                12.3.1.2.1. Amebicides
                12.3.1.2.2. Sulfonamides
                12.3.1.2.3. Quinolones and Fluoroquinolones
                12.3.1.2.4. Lincomycin Derivatives
                12.3.1.2.5. Miscellaneous Antibiotics
            12.3.1.3. Anticholinergics/Antispasmodics
        12.3.2. Nutritional Supplements
        12.3.3. Probiotics
    12.4. Market Value Forecast, by Route of Administration, 2017-2031
        12.4.1. Oral
        12.4.2. Parenteral
    12.5. Market Value Forecast, by Distribution Channel, 2017-2031
        12.5.1. Hospital Pharmacies
        12.5.2. Retail Pharmacies
        12.5.3. Online Pharmacies
    12.6. Market Attractiveness Analysis
        12.6.1. By Type
        12.6.2. By Treatment
        12.6.3. By Route of Administration
        12.6.4. By Distribution Channel
13. Competition Landscape
    13.1. Market Player - Competition Matrix (by tier and size of companies)
    13.2. Market Share Analysis, by Company, 2022
    13.3. Company Profiles
        13.3.1. Pfizer, Inc.
            13.3.1.1. Company Overview
            13.3.1.2. Product Portfolio
            13.3.1.3. SWOT Analysis
            13.3.1.4. Strategic Overview
        13.3.2. Novartis AG
            13.3.2.1. Company Overview
            13.3.2.2. Product Portfolio
            13.3.2.3. SWOT Analysis
            13.3.2.4. Strategic Overview
        13.3.3. Bayer AG
            13.3.3.1. Company Overview
            13.3.3.2. Product Portfolio
            13.3.3.3. SWOT Analysis
            13.3.3.4. Strategic Overview
        13.3.4. F. Hoffmann-La Roche Ltd.
            13.3.4.1. Company Overview
            13.3.4.2. Product Portfolio
            13.3.4.3. SWOT Analysis
            13.3.4.4. Strategic Overview
        13.3.5. Teva Pharmaceutical Industries Ltd
            13.3.5.1. Company Overview
            13.3.5.2. Product Portfolio
            13.3.5.3. SWOT Analysis
            13.3.5.4. Strategic Overview
        13.3.6. Sun Pharmaceutical Industries Ltd.
            13.3.6.1. Company Overview
            13.3.6.2. Product Portfolio
            13.3.6.3. SWOT Analysis
            13.3.6.4. Strategic Overview
        13.3.7. Johnson & Johnson
            13.3.7.1. Company Overview
            13.3.7.2. Product Portfolio
            13.3.7.3. SWOT Analysis
            13.3.7.4. Strategic Overview
        13.3.8. Mallinckrodt Pharmaceuticals
            13.3.8.1. Company Overview
            13.3.8.2. Product Portfolio
            13.3.8.3. SWOT Analysis
            13.3.8.4. Strategic Overview
        13.3.9. Abbott Laboratories
            13.3.9.1. Company Overview
            13.3.9.2. Product Portfolio
            13.3.9.3. SWOT Analysis
            13.3.9.4. Strategic Overview
        13.3.10. GSK plc
            13.3.10.1. Company Overview
            13.3.10.2. Product Portfolio
            13.3.10.3. SWOT Analysis
            13.3.10.4. Strategic Overview



List of Figures

List of Figures

Figure 01: North America Diverticular Treatment Market Value (US$ Mn) Forecast, 2017-2031

Figure 02: North America Diverticular Treatment Market Value Share, by Type, 2022

Figure 03: North America Diverticular Treatment Market Value Share, by Treatment, 2022

Figure 04: North America Diverticular Treatment Market Value Share, by Route of Administration, 2022

Figure 05: North America Diverticular Treatment Market Value Share, by Distribution Channel, 2022

Figure 06: North America Diverticular Treatment Market Value Share Analysis, by Type, 2022 and 2031

Figure 07: North America Diverticular Treatment Market Attractiveness Analysis, by Type, 2023-2031

Figure 08: North America Diverticular Treatment Market (US$ Mn), by Diverticulosis, 2017-2031

Figure 09: North America Diverticular Treatment Market (US$ Mn), by Diverticulitis, 2017-2031

Figure 10: North America Diverticular Treatment Market (US$ Mn), by Diverticular Hemorrhage, 2017-2031

Figure 11: North America Diverticular Treatment Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 12: North America Diverticular Treatment Market Attractiveness Analysis, by Treatment, 2023-2031

Figure 13: North America Diverticular Treatment Market (US$ Mn), by Medication, 2017-2031

Figure 14: North America Diverticular Treatment Market (US$ Mn), by Nutritional Supplements, 2017-2031

Figure 15: North America Diverticular Treatment Market (US$ Mn), by Probiotics, 2017-2031

Figure 16: North America Diverticular Treatment Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 17: North America Diverticular Treatment Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 18: North America Diverticular Treatment Market (US$ Mn), by Oral, 2017-2031

Figure 19: North America Diverticular Treatment Market (US$ Mn), by Parenteral, 2017-2031

Figure 20: North America Diverticular Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 21: North America Diverticular Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Figure 22: North America Diverticular Treatment Market (US$ Mn), by Hospital Pharmacies, 2017-2031

Figure 23: North America Diverticular Treatment Market (US$ Mn), by Retail Pharmacies, 2017-2031

Figure 24: North America Diverticular Treatment Market (US$ Mn), by Online Pharmacies, 2017-2031

Figure 25: North America Diverticular Treatment Market Value Share Analysis, by Country, 2022 and 2031

Figure 26: North America Diverticular Treatment Market Attractiveness Analysis, by Country, 2023-2031

Figure 27: U.S. Diverticular Treatment Market Value (US$ Mn) Forecast, 2017-2031

Figure 28: U.S. Diverticular Treatment Market Value Share Analysis, by Type, 2022 and 2031

Figure 29: U.S. Diverticular Treatment Market Attractiveness Analysis, by Type, 2023-2031

Figure 30: U.S. Diverticular Treatment Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 31: U.S. Diverticular Treatment Market Attractiveness Analysis, by Treatment, 2023-2031

Figure 32: U.S. Diverticular Treatment Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 33: U.S. Diverticular Treatment Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 34: U.S. Diverticular Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 35: U.S. Diverticular Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Figure 36: Canada Diverticular Treatment Market Value (US$ Mn) Forecast, 2017-2031

Figure 37: Canada Diverticular Treatment Market Value Share Analysis, by Type, 2022 and 2031

Figure 38: Canada Diverticular Treatment Market Attractiveness Analysis, by Type, 2023-2031

Figure 39: Canada Diverticular Treatment Market Value Share Analysis, by Treatment, 2022 and 2031

Figure 40: Canada Diverticular Treatment Market Attractiveness Analysis, by Treatment, 2023-2031

Figure 41: Canada Diverticular Treatment Market Value Share Analysis, by Route of Administration, 2022 and 2031

Figure 42: Canada Diverticular Treatment Market Attractiveness Analysis, by Route of Administration, 2023-2031

Figure 43: Canada Diverticular Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 44: Canada Diverticular Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Figure 45: North America Diverticular Treatment Market Share, by Company, 2022

List of Tables

List of Tables

Table 01: North America Diverticular Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 02: North America Diverticular Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031

Table 03: North America Diverticular Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031

Table 04: North America Diverticular Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017-2031

Table 05: North America Diverticular Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 06: North America Diverticular Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

Table 07: North America Diverticular Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 08: U.S. Diverticular Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 09: U.S. Diverticular Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031

Table 10: U.S. Diverticular Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031

Table 11: U.S. Diverticular Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017-2031

Table 12: U.S. Diverticular Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 13: U.S. Diverticular Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

Table 14: Canada Diverticular Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 15: Canada Diverticular Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031

Table 16: Canada Diverticular Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031

Table 17: Canada Diverticular Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017-2031

Table 18: Canada Diverticular Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031

Table 19: Canada Diverticular Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031